Status:
UNKNOWN
Serum Proteomics Analysis for Sepsis
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
SIRS
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
Serum proteomics is a very useful tool to identify various disease. The purpose of the present study was to find differential proteins among patient with normal, SIRS, sepsis, severe sepsis, death and...
Eligibility Criteria
Inclusion
- Male and female aged 18 years old and over;
- clinically confirmed infection;
- fulfilled at least two criteria of systemic inflammatory response syndrome
- (a) core temperature higher than 38 °C or lower than 36 °C
- (b)respiratory rate above 20/min, or PCO2 below 32 mmHg
- (c) pulse rate above 90/min, and
- (d) white blood cell count greater than 12,000/μl or lower than \< 4,000/μl or less than 10% of bands.
Exclusion
- younger than 18 years of age;
- acquired immunodeficiency syndrome;
- reduced polymorphonuclear granulocyte counts (\< 500 μL-1);
- died within 24h after admission into the ICU, or refused to participate in the study, or declined treatment during the period of observation.
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01493466
Start Date
May 1 2010
End Date
March 1 2012
Last Update
December 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijin, Beijing Municipality, China, 100853